Mineralocorticoid Receptor

Mineralocorticoid Receptor产品

目录号	产品描述	文献引用	实验数据
S1707	Eplerenone (CGP 30083) Eplerenone (CGP 30083, SC-66110) 是一类mineralocorticoid receptor 拮抗剂，阻断了醛固酮的作用，用于控制高血压。	Oncol Rep, 2021, 46(3)202 BMJ Open Diabetes Res Care, 2020, Int J Mol Sci, 2019, 20(4)
S5273	Canrenone Canrenone (Aldadiene, SC-9376, RP-11614, 6,7-Dehydro-7α-desthioacetylspironolactone), a cardiovascular drug, a sort of steroid, is spironolactone's major metabolite and has been widely used as a nonselective aldosterone receptor antagonist clinically to treat heart failure, high blood pressure, edema, liver ascites, and other cardiovascular diseases.
S9702New	Finerenone Finerenone (FIN, BAY 94-8862) 是一种高度选择性的、口服活性的 mineralocorticoid receptor (MR) 的非甾体拮抗剂，IC50值为18 nM。Finerenone 具有研究诸如2型糖尿病和慢性肾脏病等心肾疾病的潜力。

目录号	产品描述	文献引用	实验数据
S1707	Eplerenone (CGP 30083) Eplerenone (CGP 30083, SC-66110) 是一类mineralocorticoid receptor 拮抗剂，阻断了醛固酮的作用，用于控制高血压。	Oncol Rep, 2021, 46(3)202 BMJ Open Diabetes Res Care, 2020, Int J Mol Sci, 2019, 20(4)
S5273	Canrenone Canrenone (Aldadiene, SC-9376, RP-11614, 6,7-Dehydro-7α-desthioacetylspironolactone), a cardiovascular drug, a sort of steroid, is spironolactone's major metabolite and has been widely used as a nonselective aldosterone receptor antagonist clinically to treat heart failure, high blood pressure, edema, liver ascites, and other cardiovascular diseases.
S9702New	Finerenone Finerenone (FIN, BAY 94-8862) 是一种高度选择性的、口服活性的 mineralocorticoid receptor (MR) 的非甾体拮抗剂，IC50值为18 nM。Finerenone 具有研究诸如2型糖尿病和慢性肾脏病等心肾疾病的潜力。